Status: Recruiting
A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969
This is a single center, phase 1, randomized, double-blind, placebo-controlled sequential study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending oral doses of ISM8969 in healthy adults and elderly participants and obese adult participants at risk of cardiovascular disease.
Participants needed: 100
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: InSilico Medicine Hong Kong LimitedUpdated: Jun 22, 2026Locations: 1
Eligibility criteria
Male or female participants, including adult participants (≥18 and <65 years of... [+8]
Columbia suicide severity rating scale (C-SSRS) score above Type 1 ideation. [+8]